19938 Federal Register / Vol. 72, No. 76 / Friday, April 20, 2007 / Notices 

HPV vaccines to section 4132(a)(1) of 

the Internal Revenue Code of 1986, as 

amended, which defines all taxable 

vaccines. 

Under the regulations governing the 

VICP, Category XIV of the Table 

specifies that ‘‘[a]ny new vaccine 

recommended by the [CDC] for routine 

administration to children, after 

publication by the Secretary of a notice 

of coverage’’ is a covered vaccine under 

the Table (42 CFR 100.3(a), Item XIV). 

As explained above, the CDC issued its 

recommendation. This notice serves to 

satisfy the regulation’s publication 

requirement. Through this notice, 

meningococcal and HPV vaccines are 

included as covered vaccines under 

Category XIV of the Table. 

Under section 2114(e) of the PHS Act, 

as amended by section 13632(a) of the 

Omnibus Budget Reconciliation Act of 

1993, coverage for a vaccine 

recommended by the CDC for routine 

administration to children shall take 

effect upon the effective date of the tax 

enacted to provide funds for 

compensation with respect to the 

vaccine included as a covered vaccine 

in the Table. Under section 408 of the 

Tax Relief and Health Care Act of 2006, 

the effective date for the excise taxes 

enacted for meningococcal vaccines 

against meningococcal disease and the 

HPV vaccine against HPV disease and 

infection applies to sale and uses on or 

after ‘‘the first day of the first month 

which begins more than 4 weeks after 

the date of the enactment of this Act.’’

It further provides that if the vaccines 

were sold on or before the effective date 

of the excise tax, but delivered after this 

date, the delivery date of such vaccines 

shall be considered the sale date. 

Under this authorizing statutory 

language, the effective date for coverage 

of the meningococcal and HPV vaccines 

under the VICP is February 1, 2007. 

Thus, meningococcal and HPV vaccines 

are included as covered vaccines under 

Category XIV of the Table as of February 

1, 2007. Petitioners may file petitions 

related to meningococcal and HPV 

vaccines as of February 1, 2007. 

Petitions filed concerning vaccinerelated injuries or deaths associated 

with meningococcal and HPV vaccines 

must be filed within the applicable 

statute of limitations. The filing 

limitations applicable to petitions filed 

with the VICP are set out in section 

2116(a) of the PHS Act (42 U.S.C. 

300aa–16(a)). Persons who may be 

eligible must file petitions within: three 

(3) years from the first symptom or 

manifestation of onset of an injury or of 

the significant aggravation of the injury; 

or two (2) years from the date of a 

vaccine-related death and four (4) years 

after the start of the first symptom of the 

vaccine-related injury from which the 

death occurred. 

In addition, section 2116(b) of the 

PHS Act lays out specific exceptions to 

these statutes of limitations that apply 

when the effect of a revision to the 

Table makes a previously ineligible 

person eligible to receive compensation 

or when an eligible person’s likelihood 

of obtaining compensation significantly 

increases. Under this provision, persons 

who may be eligible to file petitions 

based on the addition of a new vaccine 

under Category XIV of the Table may 

file a petition for compensation not later 

than 2 years after the effective date of 

the revision if the injury or death 

occurred not more than 8 years before 

the effective date of the revision of the 

Table (42 U.S.C. 300aa–16(b)). Thus, 

persons whose petitions may not be 

timely under the limitations periods 

described in section 2116(a) of the PHS 

Act, may still file petitions concerning 

vaccine-related injuries or deaths 

associated with meningococcal and HPV 

vaccines until February 2, 2009, as long 

as the vaccine-related injury or death 

occurred on or after February 1, 1999 (8 

years prior to the effective date of the 

addition that included meningococcal 

vaccines and HPV as covered vaccines). 

Although two years from the date of 

February 1, 2007, would be February 1, 

2009, under the current Rules of the 

United States Court of Federal Claims, 

the deadline under section 2116(b) of 

the PHS Act would be February 2, 2009, 

because February 1, 2009, falls on a 

Sunday. 

The Secretary plans to amend the 

Table through the rulemaking process 

by including meningococcal and HPV 

vaccines as separate categories of 

vaccines in the Table. February 1, 2007, 

will remain the applicable effective date 

when the Secretary makes a 

corresponding amendment to add 

meningococcal and HPV vaccines as 

separate categories on the Table through 

rulemaking. 

Dated: April 16, 2007. 

Elizabeth M. Duke, 

Administrator. 

[FR Doc. E7–7591 Filed 4–19–07; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Heart, Lung, and Blood 

Advisory Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Advisory Council. 

Date: June 5, 2007. 

Open: 8:30 a.m. to 12 p.m. 

Agenda: To discuss program policies and 

issues. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Conference 

Room 10, Bethesda, MD 20892. 

Closed: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Conference 

Room 10, Bethesda, MD 20892. 

Contact Person: Stephen Mockrin, PhD., 

Director, Division of Extramural Research 

Activities, National Institutes of Health, 6701 

Rockledge Drive, Room 7100, Bethesda, MD 

20892, (301) 435–0260, 

mockrins@nhlbi.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: 

www.nhlbi.nih.gov/meetings/index.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 


sroberts on PROD1PC70 with NOTICES
Federal Register / Vol. 72, No. 76 / Friday, April 20, 2007 / Notices 19939 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: April 12, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–1964 Filed 4–19–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Advisory Council on Aging. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council on Aging. 

Date: May 15–16, 2007. 

Closed: May 15, 2007, 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, 9000 Rockville Pike, Conference 

Room 6, Rockville, MD 20892. 

Open: May 16, 2007, 8 a.m. to 1 p.m. 

Agenda: Call to Order, Task Force on 

Minority Aging Research Report; Working 

Group on Program Report; and Program 

Highlights. 

Place: National Institutes of Health, 

Building 31, 9000 Rockville Pike, Conference 

Room 6, Rockville, MD 20892. 

Contact Person: Robin Barr, PhD, Director, 

Office of Extramural Affairs, National 

Institute on Aging, 7201 Wisconsin Avenue, 

Gateway Bldg., Suite 2C218, Bethesda, MD 

20814, 301–496–9322. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.nih.gov/nia/naca/, where an agenda 

and any additional information for the 

meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: April 12, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–1960 Filed 4–19–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in section 552b(c)(4) 

and 552b(c)(6), Title 5 U.S.C., as 

amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Neural and 

Behavioral Studies in Aging. 

Date: April 20, 2007. 

Time: 1 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C212, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Louise L. Hsu, PhD., 

Scientific Review Administrator, Scientific 

Review Office, National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue/ 

Suite 2C212, Bethesda, MD 20892, (301) 496–

7705, hsul@exmur.nia.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Loan 

Repayment. 

Date: April 27, 2007. 

Time: 8 a.m. to 12 p.m. 

Agenda: To review and evaluate loan 

Repayment. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C212, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: William Cruse, PhD., 

Health Scientist Administrator, Scientific 

Review Office, National Institute on Aging, 

National Institutes of Health, Room 2C212, 

7201 Wisconsin Avenue, Bethesda, MD 

20814, 301–402–7704, Crucew@nia.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Cognitive 

Aging in Prefrontal Cortex. 

Date: May 4, 2007. 

Time: 9:30 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Suite 2C212, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Elaine Lewis, PhD, 

Scientific Review Administrator, Scientific 

Review Office, National Institute on Aging, 

Gateway Building, Suite 2C212, MSC–9205, 

7201 Wisconsin Avenue, Bethesda, MD 

20892, 301–402–7707, 

elainelewis@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Thrombosis 

RFA Review. 

Date: May 7–8, 2007. 

Time: 6 p.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Bethesda Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Ramesh Vemuri, PhD, 

Scientific Review Office, National Institute 

on Aging, National Institutes of Health, 7201 

Wisconsin Avenue, Suite 2C–212, Bethesda, 

MD 20892, 301–402–7700, rv23@nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Thrombosis 

RFA Review 

Date: May 8, 2007. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Bethesda Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Ramesh Vemuri, PhD, 

Scientific Review Office, National Institute 

on Aging, National Institutes of Health, 7201 

Wisconsin Avenue, Suite 2C–212, Bethesda, 

MD 20892, 301–402–7700, rv23@nih.gov. 


sroberts on PROD1PC70 with NOTICES